Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

MP Healthcare Venture Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 43
Average round size
info
The average size of a deal this fund participated in
$20M
Portfolio companies 24
Rounds per year 2.39
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.44
Exits 8
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Biopharma
Summary

In 2006 was created MP Healthcare Venture Management, which is appeared as VC. The leading representative office of defined VC is situated in the Boston. The venture was found in North America in United States.

We also calculated 1 valuable employee in our database.

The fund has no exact preference in a number of founders of portfolio startups. If startup sums 2 or 4 of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Thrasos, Genkyotex, Covagen For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Biotechnology, Medical.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the MP Healthcare Venture Management, startups are often financed by Atlas Venture, SR One, Amgen Ventures. The meaningful sponsors for the fund in investment in the same round are SR One, M Ventures, Atlas Venture. In the next rounds fund is usually obtained by SR One, Andera Partners, Ventech.

The fund is generally included in 2-6 deals every year. The increased amount of exits for fund were in 2014. The high activity for fund was in 2009. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 16 percentage points less often commits exit comparing to other organizations. This MP Healthcare Venture Management works on 0 percentage points less the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arancia International Guadalajara, Jalisco, Mexico
Ascenion GmbH -
BASF Canada Canada, Ontario, Windsor
East of England Co-operative Society Limited -
Enable Capital Management California, San Francisco, United States
GPS Ventures GmbH Berlin, Berlin, Germany
Guanrong Touzi China, Guangdong, Shenzhen
Jan Cieslikiewicz Ventures Brooklyn, New York, United States
KCB Group Kenya, Nairobi, Nairobi Area
Marin Investments British Columbia, Canada, Vancouver
Matsui Securities Chiyoda, Japan
Michigan Rise -
Newsinvest France, Ile-de-France, Paris
Shin Nippon Biomedical Laboratories (SNBL) Chiyoda, Japan
Suzhou Nongfa Chuangxin China, Jiangsu, Suzhou
Tiansheng China, Jinhua, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Draupnir Bio

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$14M17 Jul 2024 Aarhus, Central Denmark Region, Denmark

Outrun TX

Health Care
Medical
Therapeutics
$10M18 Apr 2024 Dundee City, Dundee, United Kingdom

PharmEnable

Biotechnology
Life Science
Medical
Pharmaceutical
$8M22 May 2023 Cambridge, England, United Kingdom

QurAlis

Biotechnology
Health Care
Therapeutics
$88M09 Mar 2023 Cambridge, Massachusetts, United States

Korro Bio

Biotechnology
Pharmaceutical
$116M05 Jan 2022 Cambridge, Massachusetts, United States

SOLA Biosciences

Alternative Medicine
Biotechnology
Food and Beverage
09 Sep 2021 Tel Aviv, Tel Aviv, Israel

SOLA Biosciences

01 Sep 2021 -

Outrun TX

Health Care
Medical
Therapeutics
01 Apr 2021 Dundee City, Dundee, United Kingdom

Blacksmith Medicines

Biotechnology
Genetics
Life Science
08 Jan 2021 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent MP Healthcare Venture Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 43
Average round size 20M
Rounds per year 2.39
Peak activity year 2021
Lead investments 3
Follow on index 0.44
Exits 8
Group Appearance index 0.91

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Draupnir Bio

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$14M17 Jul 2024 Aarhus, Central Denmark Region, Denmark

Outrun TX

Health Care
Medical
Therapeutics
$10M18 Apr 2024 Dundee City, Dundee, United Kingdom

PharmEnable

Biotechnology
Life Science
Medical
Pharmaceutical
$8M22 May 2023 Cambridge, England, United Kingdom

QurAlis

Biotechnology
Health Care
Therapeutics
$88M09 Mar 2023 Cambridge, Massachusetts, United States

Korro Bio

Biotechnology
Pharmaceutical
$116M05 Jan 2022 Cambridge, Massachusetts, United States

SOLA Biosciences

Alternative Medicine
Biotechnology
Food and Beverage
09 Sep 2021 Tel Aviv, Tel Aviv, Israel

SOLA Biosciences

01 Sep 2021 -

Outrun TX

Health Care
Medical
Therapeutics
01 Apr 2021 Dundee City, Dundee, United Kingdom

Blacksmith Medicines

Biotechnology
Genetics
Life Science
08 Jan 2021 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: